Welcome, Guest
Username: Password: Remember me

Profile for Selinexor Sensitizes TRAIL-R2-Positive TNBC Tissues towards the Action of TRAIL-R2xCD3 Bispecific Antibody. (coffeemoat4)

coffeemoat4's Avatar
  • OFFLINE
  • Rank: Fresh Boarder
  • Register Date: 18 Jan 2024
  • Last Visit Date: 18 Jan 2024
  • Time Zone: GMT -6:00
  • Local Time: 13:25
  • Profile Views: 14
  • Karma: 0
  • Location: Unknown
  • Gender: Unknown
  • Birthdate: Unknown

Signature

Posts

Recent Posts

No Posts
Time to create page: 0.316 seconds
Go to top